Vaddi Krishna
SEC CIK 1824633 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Pres, CEO, Dir | 2.00M | $871.9K | — | 12 | 2021-12-13 | 2025-03-25 |
Most active insiders at PRLD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bonita David P | Dir, 10% | $12.50M | — |
| 2 | ORBIMED ADVISORS LLC | Dir, 10% | $12.50M | — |
| 3 | Huang Jane | Pres, CMO | — | — |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | — |
Vaddi Krishna made no open-market trades at PRLD in the last 12 months.
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-27 | 2025-03-25 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $0.69 | +675.0K | 2.00M | +51% | +$465.7K | |
| M | 2025-03-24 | 2025-03-20+ | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $0.73 | +20.4K | 1.32M | +2% | +$14.9K |
| M | 2025-03-18 | 2025-03-14+ | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $0.75 | +39.1K | 1.29M | +3% | +$29.3K |
| M | 2025-03-14 | 2025-03-12+ | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $0.7151 | +97.5K | 1.26M | +8% | +$69.7K |
| I | 2025-01-03 | 2024-12-31 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $1.21 | +5,000 | 142.6K | +4% | +$6,050 |
| I | 2025-01-02 | 2024-12-30 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $1.20 | +10.0K | 137.6K | +8% | +$12.0K |
| 2024-12-20 | 2024-12-18 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $0.93 | +100.0K | 1.17M | +9% | +$93.0K | |
| I | 2024-12-20 | 2024-12-19 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $0.89 | +6,888 | 127.6K | +6% | +$6,130 |
| M | 2023-05-26 | 2023-05-24+ | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $5.15 | +1,900 | 1.07M | +0.2% | +$9,789 |
| 2023-05-25 | 2023-05-23 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $5.63 | +11.9K | 1.07M | +1% | +$66.7K | |
| I | 2022-12-21 | 2022-12-20 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | CEO, Dir | P - Purchase | $5.13 | +19.2K | 120.7K | +19% | +$98.4K |
| 2021-12-14 | 2021-12-13 | PRLD | Prelude Therapeutics Inc | Vaddi Krishna | Pres, CEO, Dir | A - Grant | $12.13 | +8,000 | 1.05M | +0.8% | +$97.0K |
Purchase Sale Sale after option exercise All abbreviations